SCHEMBL1628916

SCHEMBL1628916

CCCCN(C)S(=O)(=O)c1cc(-c2ccnn2-c2ccccc2Cl)c(O)cc1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 8/20 0.49
NR3C2 P08235 1/20 0.37
PDE11A Q9HCR9 1/20 0.36
MAPT P10636 1/20 0.35
TP53 P04637 1/20 0.35
CYP2C8 P10632 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C18 P33260 1/20 0.34
CYP2C19 P33261 1/20 0.34
MAPK14 Q16539 1/20 0.34
ESR1 P03372 2/20 0.33
LMNA P02545 2/20 0.33
TSHR P16473 2/20 0.33
MEN1 O00255 1/20 0.32
USP2 O75604 1/20 0.32
ALDH1A1 P00352 1/20 0.32
ALOX15 P16050 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1629115 0.94 HSP90AA1 (0.51) HSP90AA1NR3C2PDE11ACYP2C8CYP2C9
SCHEMBL1629130 0.90 HSP90AA1 (0.49) HSP90AA1NR3C2PDE11AMAPTTP53
SCHEMBL1629206 0.90 HSP90AA1 (0.51) HSP90AA1NR3C2PDE11ATP53MAPK14
SCHEMBL1630250 0.87 HSP90AA1 (0.46) HSP90AA1NR3C2PDE11AMAPK14ALDH1A1
SCHEMBL1629715 0.86 HSP90AA1 (0.52) HSP90AA1NR3C2PDE11AMAPTMAPK14
SCHEMBL1216341 0.86 HSP90AA1 (0.48) HSP90AA1NR3C2TP53LMNAMEN1
SCHEMBL1217338 0.86 HSP90AA1 (0.51) HSP90AA1NR3C2PDE11ATP53MAPK14
SCHEMBL1629701 0.85 HSP90AA1 (0.52) HSP90AA1NR3C2PDE11ACYP2C9CYP2C19
SCHEMBL1629084 0.85 HSP90AA1 (0.50) HSP90AA1NR3C2PDE11AMAPK14ALDH1A1
SCHEMBL1630393 0.84 HSP90AA1 (0.38) HSP90AA1NR3C2PDE11AMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP claimed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US claimed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US claimed
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885NR3C2 558/4885PDE11A 4692/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.